Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|November 3, 2010
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response studyM Goldberg, Y-P Li, J F Johanson, et al.Cephalalgia : an International Journal of Headache|May 1, 1997
Naratriptan: biological profile in animal models relevant to migraineH E Connor, W Feniuk, D T Beattie, et al.Neuropharmacology|March 12, 2011
5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessmentFei Shen, Jacqueline A M Smith, Ray Chang, et al.Gerontology|April 7, 2021
Age Predicts Older Adults' Driving Self-Regulation but Not Dangerous Driving Behaviors after Controlling for Executive FunctionJohn P K Bernstein, Nora Mattek, Katherine E Dorociak, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Dementia Care Research and Psychosocial FactorsWan-Tai Michael Au-Yeung, Lyndsey M Miller, Allison Lindauer, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Technology and Dementia PreconferenceWan-Tai Michael Au-Yeung, Lyndsey M Miller, Allison Lindauer, et al.Journal of Inflammation (London, England)|December 12, 2017
Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapyDavid T Beattie, M Teresa Pulido-Rios, Fei Shen, et al.Infection and Immunity|July 1, 1995
Heterologous antigen expression in Vibrio cholerae vector strainsJ R Butterton, D T Beattie, C L Gardel, et al.Vascular Pharmacology|December 4, 2012
An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954D T Beattie, D L Higgins, M P Ero, et al.Regulatory Peptides|August 27, 1996
GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activityC J Gardner, D R Armour, D T Beattie, et al.Pageof 12